A PCR-based reverse hybridization system (research prototype kit INNO-LiPA for H. pylori resistance) was developed and evaluated for simultaneous detection of 23S ribosomal DNA point mutations, associated with macrolide resistance in Helicobacter pylori. Fifty-seven H. pylori strains (51 natural, 6 laboratory-derived artificial, 52 resistant, and 5 susceptible strains) were tested by PCR-LiPA (detecting mutations A21153G, G21413A, A21423G, A21423C, A21433G, A21433C, and A21433T), DNA sequencing, restriction fragment length polymorphism, and/or hybridization to oligonucleotide probes. Results were highly concordant, but PCR-LiPA appears to be more sensitive for the simultaneous detection of multiple mutants.
Helicobacter pylori is a gram-negative bacterium that colonizes the human stomach. Infection with H. pylori is associated with gastritis and peptic ulcer disease and may eventually result in the development of atrophic gastritis and gastric cancer (1, 7) .
Infection with H. pylori can be effectively treated by a combination of proton pump inhibitors and/or H 2 receptor antagonists and antibiotics. Metronidazole, amoxicillin, clarithromycin, and tetracycline are frequently included in the triple or quadruple treatment regimens used to eradicate H. pylori (5, 18) . Resistance to antimicrobial agents is an important factor for the clinical outcome of anti-Helicobacter treatment. Resistance to metronidazole is observed in 10 to 50% of the cases in developed countries but can be as high as 90% in developing countries (12) . Resistance to macrolides also is of importance and was found in less than 2% of the strains in The Netherlands (19) but in more than 10% of those from France as well as some other countries (2, 6, 12, 14) . The prevalence of resistant strains appears to be increasing (6, 8, 11, 17) .
The major cause of macrolide resistance in H. pylori is the lack of binding of the macrolides to the 23S rRNA components of the bacterial ribosome due to a modification of the target site by methylation or point mutations in the peptidyltransferase region of domain V of the 23S rRNA (21) . H. pylori contains two copies of the 23S ribosomal DNA (rDNA) gene, and at least five distinct point mutations have been reported that are associated with macrolide resistance. Versalovic et al. (20) found A3G transitions at two positions (A21423G and A21433G). Also, an A3C transversion (A21423C) was found to be related to resistance (15) . Recently, Hultén et al. described associated mutations at two additional positions (G21153A and G21413A) (10) . The conventional method to determine the antibiotic resistance of H. pylori is based on analysis of cultured strains by agar diffusion or the E test (12, 13) , which is time-consuming and requires specific expertise. Therefore, DNA-based diagnostic methods may offer a rapid and reliable alternative approach for macrolide susceptibility testing. The present study describes a convenient method, based on PCR and reverse hybridization, for the detection of the relevant mutations in the 23S rDNA.
Bacterial strains. Bacteria were cultured on Trypticase-soy agar plates containing 5% sheep blood (Becton Dickinson) for 3 to 5 days at 37°C under microaerobic conditions (5% O 2 , 10% CO 2 , and 80% N 2 ). The susceptibility to clarithromycin of each strain and MICs for each strain were determined with the E test (AB Biodisk, Solwa, Sweden) (4, 9, 13) or by the standard agar dilution technique, as described previously (12, 15) . DNA isolation from cultured strains. The H. pylori cells were harvested from the plate by suspension in 2 ml of sterile 0.9% NaCl solution and pelleted by centrifugation at 10,000 ϫ g for 2 min. Cells were resuspended in 400 l of a solution containing 10 mM Tris-HCl (pH 8.0), 5 mM EDTA, 0.1% sodium dodecyl sulfate, and 0.1 mg of proteinase K per ml and incubated for 2 to 4 h at 55°C. Proteinase K was inactivated by incubation at 95°C for 10 min. The lysates were diluted 1/100 in sterile water and directly used for PCR.
Analysis of 23S rRNA mutations by RFLP and/or direct sequencing. Mutations A2142G and A2143G were analyzed by restriction fragment length polymorphism (RFLP) with restriction enzyme AvaII, BsaI, MboII, or BbsI as described earlier or by probe hybridization in liquid phase (15, 16) . 23S rRNA sequences were determined by direct sequencing of PCR products (3, 4) .
PCR-LiPA. A fragment of the 23S rRNA gene was amplified by PCR. PCRs were performed in a volume of 50 l, containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mM MgCl 2 , 200 M concentrations of deoxynucleoside triphosphates, 0.25 U of AmpliTaq Gold, and 25 pmol of biotinylated PCR primers. Reaction mixtures were covered with mineral oil, and PCR was performed in a BioMed-60 thermocycler, under the following conditions: 9 min of preincubation at 94°C, followed by 40 cycles of 30 s at 95°C, 45 s at 62°C, and 45 s at 72°C. A final extension was performed for 5 min at 72°C. PCR products were analyzed by reverse hybridization in a reverse hybridization line probe assay (LiPA). This assay is based on hybridization to a number of oligonucleotide probes, immobilized as parallel lines on a nitrocellulose strip (Fig. 1) . For each strain, 10 l of the PCR product was analyzed on the LiPA strip, essentially as described for the LiPA detection of vacA and cagA genotypes (18a).
Analysis of 23S rDNA mutations in H. pylori strains by PCR-LiPA. PCR primers for the 23S rDNA of H. pylori were tested on chromosomal DNA from multiple bacterial species. PCR products of the expected size were obtained only from H. pylori, H. nemestrinae, and H. acinonyx. Specific probes were developed for reverse hybridization analysis in a line probe assay, covering the relevant positions of the 23S rDNA. The PCR fragments from H. nemestrinae and H. acinonyx showed hybridization only to the wild-type probes.
To evaluate the performance of the PCR-LiPA, a total of 57 H. pylori strains were analyzed. Of these, 51 were clinical isolates, directly derived from patients, and 6 were laboratory- derived artificial mutant H. pylori strains (3). Of the 57 strains, 52 were resistant, whereas 5 strains were susceptible (MIC Ͻ 2). Sequences of the 23S rRNA gene also were analyzed by PCR followed by a combination of direct sequencing, RFLP, and/or probe hybridization as described (3, 4, 15, 16) . All results for the individual strains are shown in Table 1 and are summarized in Table 2 .
In 52 (91.2%) of the 57 isolates studied, PCR-LiPA yielded exactly the same results as conventional methods (direct sequencing, probe hybridization in liquid phase, and/or restriction enzyme analysis). These included the natural strains, including the wild type (n ϭ 5) and strains with mutations A21423G (n ϭ 19), A21423C (n ϭ 1), A21433G (n ϭ 19), or a combination (n ϭ 3), derived from patients, as well as five of the six artificial mutants, with mutations A21423G, A21423C, A21423T, A21433G, and A21433C, respectively. No strains were found that contained the combined A21153G and G21413A mutations (10) , which may indicate that such mutants are extremely rare. All strains showing discrepant results were retested by the conventional methods as well as by LiPA. In three of the clinical strains, multiple mutants were detected by conventional methods (strains 1538, LINAN 1567, and PAP), and PCR-LiPA yielded exactly the same results.
The initially seemingly discrepant results observed in five strains can all be attributed to the high sensitivity of the PCRLiPA method. Strain 140-97, containing the wild-type 23S sequence, as determined by conventional methods, yielded a LiPA pattern indicating the presence of the wild-type sequence, as well as A21423G and A21433G mutations. The strain yielded variable MICs, ranging from less than 2 to more than 256, suggesting the presence of a mixture of strains. Two isolates (1264 and 1470) contained the A21423G mutation, but PCR-LiPA also showed the presence of other mutants. Both strains were macrolide resistant, and the MICs for them were higher than 256. Similarly, the MIC for strain 1075 exceeded 256, and sequence analysis detected only the A21433G mutation, but PCR-LiPA also detected the A21423G mutation.
In the clinically macrolide-susceptible strain (ABT2-16), containing the artificial mutation A21433T, the wild-type sequence as well as the mutant A21433T sequence was detected by sequence analysis. The LiPA does not contain a probe specific for A21433T, since it was shown earlier that the A21433T mutation was not stable and rapidly mutated back to the wild-type sequence during subsequent passages (3). Since we tested the fourth passage of this strain, the PCRLiPA result is consistent with these data.
Interestingly, strain C3II contained only wild-type sequences, as determined by all methods. However, this strain was clearly resistant, since the MIC for it was higher than 256. This strain is not a clinical isolate, but resistance to clarithromycin was selected in this strain in the laboratory by exposure to increased concentrations of clarithromycin (data not shown). Therefore, this strain may well have developed a different mechanism of resistance (12) . Compared to the conventional methods, the PCR-LiPA detected additional mutants and appears to provide more accurate data about the presence of bacterial variants in the culture, especially when multiple strains are present. In contrast, direct sequence analysis of PCR products will often detect only the predominant sequence. Only if different mutants are present in approximately similar concentrations are they detected by sequence analysis, whereas the LiPA specifically detects small amounts of each mutant. Also, the LiPA format permits the addition of specific probes in case additional relevant mutations are found. Thus, the LiPA provides accurate information about the presence of different 23S rDNA mutants, even if they represent only a small proportion of a bacterial population. Therefore, it could be particularly suitable to monitor the development of resistance during antibiotic therapy. The method can also be used directly in gastric biopsies, without the need for a bacterial culture (data not shown). Sometimes, the presence of multiple strains is also indicated by the presence of apparently resistant colonies within the growth inhibition zone on agar plates. This phenomenon is illustrated by the four strains in which PCR-LiPA showed the presence of multiple mutants, whereas conventional 23 rDNA analyses detected only a single wild-type or mutant sequence.
In conclusion, the PCR-LiPA offers a rapid and easy method for the detection of clinically relevant mutations in the 23S rRNA gene of H. pylori. The high sensitivity of the reverse hybridization method provides more accurate data, especially when multiple strains are present. Therefore, this method could facilitate further epidemiological and clinical studies. 
